These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11982810)

  • 1. Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge.
    Levin A
    Kidney Int Suppl; 2002 May; (80):35-8. PubMed ID: 11982810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
    Levin A
    Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy in chronic kidney disease. Is pulse pressure an independent risk factor?
    Gjata M; Nelaj E; Collaku L; Gjergji Z; Tase M
    Med Arh; 2011; 65(1):30-1. PubMed ID: 21534449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease in patients with chronic kidney disease.
    Jaradat MI; Molitoris BA
    Semin Nephrol; 2002 Nov; 22(6):459-73. PubMed ID: 12430090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, left ventricular hypertrophy and chronic kidney disease.
    Taddei S; Nami R; Bruno RM; Quatrini I; Nuti R
    Heart Fail Rev; 2011 Nov; 16(6):615-20. PubMed ID: 21116711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia and the heart in chronic kidney disease.
    Zalunardo N; Levin A
    Semin Nephrol; 2006 Jul; 26(4):290-5. PubMed ID: 16949467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease in chronic renal insufficiency.
    Levin A; Foley RN
    Am J Kidney Dis; 2000 Dec; 36(6 Suppl 3):S24-30. PubMed ID: 11118155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
    Weiner DE; Tighiouart H; Vlagopoulos PT; Griffith JL; Salem DN; Levey AS; Sarnak MJ
    J Am Soc Nephrol; 2005 Jun; 16(6):1803-10. PubMed ID: 15857925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review.
    Cerasola G; Nardi E; Palermo A; Mulè G; Cottone S
    J Nephrol; 2011; 24(1):1-10. PubMed ID: 20437402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient.
    Schmid H; Schiffl H; Lederer SR
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):465-70. PubMed ID: 21738032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beneficial effects of intervention in early renal disease.
    Portolés J
    Nephrol Dial Transplant; 2001; 16 Suppl 2():12-5. PubMed ID: 11369843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Left ventricular hypertrophy in chronic kidney disease].
    Paoletti E; Cannella G
    G Ital Nefrol; 2006; 23(6):560-8. PubMed ID: 17173262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of anemia, secondary hyperparathyroidism with left ventricular hypertrophy in Chronic Kidney Disease patients.
    Datta S; Abraham G; Mathew M; Somasundaram H; Muralidharan TR; Moorthy A; Sathyasekaran ; Leslie N
    J Assoc Physicians India; 2006 Sep; 54():699-703. PubMed ID: 17212016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaemia and early phase cardiovascular events on haemodialysis.
    Hayashi T; Joki N; Tanaka Y; Hase H
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():1-6. PubMed ID: 26456311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?
    Covic A; Voroneanu L; Goldsmith D
    Nephron Clin Pract; 2010; 116(3):c187-95. PubMed ID: 20606478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.
    Berweck S; Hennig L; Sternberg C; Dingerkus H; Ludat K; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S80-5. PubMed ID: 10746811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B; Petrović D; Obrenović R
    Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anemia on cardiac disorders in pre-dialysis patients immediately before starting hemodialysis.
    Kuwahara M; Iimori S; Kuyama T; Akita W; Mori Y; Asai T; Tsukamoto Y; Adachi S; Rai T; Uchida S; Sasaki S
    Clin Exp Nephrol; 2011 Feb; 15(1):121-5. PubMed ID: 21069412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.